Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
DexCom Inc
DXCMCurrent price
70.69 USD
+2.1 USD (+3.06%)
Last closed
68.48 USD
Company
www.dexcom.com
ISIN
US2521311074
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
Capitalization
30 150 088 704 USD
Yield for 12 month
-45.81 %
1Y
3Y
5Y
10Y
15Y
DXCM
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California. Address: 6340 Sequence Drive, San Diego, CA, United States, 92121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
96.10 USDP/E ratio
46.59Dividend Yield
–Current Year
+3 622 300 000 USD
Last Year
+2 909 800 000 USD
Current Quarter
+994 200 000 USD
Last Quarter
+1 004 300 000 USD
Current Year
+2 288 900 000 USD
Last Year
+1 883 100 000 USD
Current Quarter
+593 800 000 USD
Last Quarter
+626 700 000 USD
Key Figures DXCM
1 year
3 years
5 years
10 years
EBITDA
840 400 000 USD
Operating Margin TTM
Price to Earnings
46.59
Return On Assets TTM
6.06 %
PEG Ratio
1.21
Return On Equity TTM
32.06 %
Wall Street Target Price
96.10 USD
Revenue TTM
3 953 999 872 USD
Book Value
5.07 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
2.00 %
Dividend Yield
–
Gross Profit TTM
1 883 100 000 USD
Earnings per share
1.64 USD
Diluted Eps TTM
1.64 USD
Most Recent Quarter
III 2024
Quarterly Earnings Growth YOY
15.70 %
Profit Margin
17.22 %
Dividend Analytics DXCM
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History DXCM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
–
Dividend CAGR 3Y
–
Dividend CAGR 5Y
–
Dividend CAGR 10Y
–
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
–
Forward Annual Dividend
– USD
Last Split Factor
4:1
Payout Ratio
–
Last Split Date
13.06.2022
Stock Valuation DXCM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
46.59
Forward PE
37.59
Enterprise Value Revenue
7.65
Price Sales TTM
7.63
Enterprise Value EBITDA
31.02
Price Book MRQ
15.24
Financials DXCM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators DXCM
For 52 weeks
62.34 USD
142.00 USD
50 Day MA
73.56 USD
Shares Short Prior Month
9 116 711
200 Day MA
98.76 USD
Short Ratio
2.11
Shares Short
8 424 177
Short Percent
2.44 %
BeatStart